blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1696962

EP1696962 - NOVEL GLP-1 ANALOGUES LINKED TO ALBUMIN-LIKE AGENTS [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  17.12.2010
Database last updated on 11.09.2024
Most recent event   Tooltip17.12.2010Withdrawal of applicationpublished on 19.01.2011  [2011/03]
Applicant(s)For all designated states
NOVO NORDISK A/S
Novo Allé
2880 Bagsværd / DK
[N/P]
Former [2006/36]For all designated states
NOVO NORDISK A/S
Novo Allé
2880 Bagsvaerd / DK
Inventor(s)01 / HANSEN, Thomas Kruse
Tibbevangen 78
DK-2730 Herlev / DK
02 / ZUNDEL, Magali
Plantevej 27, 3 t.h.
DK-2860 Soborg / DK
03 / MADSEN, Kjeld
Nyvestergardsvej 3
DK-3500 Vaerlose / DK
04 / SVENDSEN, Anne
Korshoj 129
DK-3670 Vekso / DK
05 / SCHIODT, Christine Bruun
Risbyholmvej 20, st
DK-2700 Bronshoj / DK
06 / LAU, Jesper
Rosenvaenget 3
DK-3520 Farum / DK
 [2006/36]
Representative(s)Nielsen, Lars Balzer, et al
Novo Nordisk A/S
Corporate Patents
Novo Allée
2880 Bagsvaerd / DK
[N/P]
Former [2007/41]Nielsen, Lars Balzer, et al
Novo Nordisk A/S Corporate Patents Novo Allée
2880 Bagsvaerd / DK
Former [2006/36]Jensen, Dorte Kold, et al
Novo Nordisk A/S, Corporate Patents, Novo Allé
2880 Bagsvaerd / DK
Application number, filing date04803038.117.12.2004
[2006/36]
WO2004DK00887
Priority number, dateDK2003000188318.12.2003         Original published format: DK 200301883
[2006/36]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2005058958
Date:30.06.2005
Language:EN
[2005/26]
Type: A2 Application without search report 
No.:EP1696962
Date:06.09.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 30.06.2005 takes the place of the publication of the European patent application.
[2006/36]
Search report(s)International search report - published on:EP24.11.2005
ClassificationIPC:A61K47/48, C07K14/47, C07K14/605, A61K38/26, A61K38/38, C07K14/765, C07K19/00, A61P3/10
[2006/36]
CPC:
C07K14/605 (EP,US); C07K14/765 (KR); A61K38/00 (EP,KR,US);
A61K47/50 (KR); A61K47/643 (EP,US); A61P1/04 (EP);
A61P25/18 (EP); A61P3/04 (EP); A61P3/06 (EP);
A61P3/10 (EP); A61P9/00 (EP); A61P9/10 (EP);
A61P9/12 (EP); C07K14/46 (EP,US); C07K14/47 (KR);
C07K14/4705 (EP,US); C07K14/57563 (EP,US); C07K2319/00 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/36]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
LVNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:MIT ALBUMINARTIGEN MITTELN VERKNÜPFTE NEUE GLP-1-ANALOGA[2006/36]
English:NOVEL GLP-1 ANALOGUES LINKED TO ALBUMIN-LIKE AGENTS[2006/36]
French:NOUVEAUX ANALOGUES GLP-1 LIES A DES AGENTS DE TYPE ALBUMINE[2006/36]
Entry into regional phase18.07.2006National basic fee paid 
18.07.2006Designation fee(s) paid 
18.07.2006Examination fee paid 
Examination procedure18.07.2006Examination requested  [2006/36]
02.10.2006Despatch of a communication from the examining division (Time limit: M06)
24.05.2007Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
11.07.2007Reply to a communication from the examining division
30.09.2008Observations by third parties
15.12.2010Application withdrawn by applicant  [2011/03]
Request for further processing for:11.07.2007Request for further processing filed
11.07.2007Full payment received (date of receipt of payment)
Request granted
09.08.2007Decision despatched
Fees paidRenewal fee
02.01.2007Renewal fee patent year 03
02.01.2008Renewal fee patent year 04
05.01.2009Renewal fee patent year 05
04.01.2010Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[DY]WO0246227  (LILLY CO ELI [US], et al) [DY] 1-43,1-43,1-43 * the whole document * * the whole document * * the whole document *;
 [Y]WO03059934  (HUMAN GENOME SCIENCES INC [US], et al) [Y] 1-43,1-43,1-43 * paragraph [0988] - paragraph [1054]; claim - * * paragraph [0988] - paragraph [1054]; claim - * * paragraph [0988] - paragraph [1054]; claim - *;
 [E]WO2004110472  (LILLY CO ELI [US], et al) [E] 1-43,1-43,1-43 * example 1 * * example 1 ** example 1 *;
 [Y]  - KIM J-G ET AL, "DEVELOPMENT AND CHARACTERIZATION OF A GLUCAGON-LIKE PEPTIDE 1-ALBUMIN CONJUGATE THE ABILITY TO ACTIVATE THE GLUCAGON-LIKE PEPTIDE 1 RECEPTOR IN VIVO", DIABETES, NEW YORK, NY, US, (200303), vol. 52, no. 3, ISSN 0012-1797, pages 751 - 759, XP008042628 [Y] 1-43,1-43,1-43 * the whole document * * the whole document * * the whole document *

DOI:   http://dx.doi.org/10.2337/diabetes.52.3.751
 [T]  - NAUCK M A ET AL, "Glucagon-like peptide 1 and its derivatives in the treatment of diabetes", REGULATORY PEPTIDES, ELSEVIER SCIENCE BV, NL, (20050615), vol. 128, no. 2, ISSN 0167-0115, pages 135 - 148, XP004789694 [T] 1-43,1-43,1-43 * figure 5 * * figure 5 * * figure 5 *

DOI:   http://dx.doi.org/10.1016/j.regpep.2004.07.014
otherUS6329336
    - KIM J-G. ET AL, "DEVELOPMENT AND CHARACTERIZATION OF A GLUCAGON-LIKE PEPTIDE 1-ALBUMIN CONJUGATE THE ABILITY TO ACTIVATE THE GLUCAGON-LIKE PEPTIDE 1 RECEPTOR IN VIVO", DIABETES, (20030301), vol. 52, no. 3, pages 751 - 759, XP008042628

DOI:   http://dx.doi.org/10.2337/diabetes.52.3.751
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.